(Q40613355)

22 September 2017

title

Estrogen receptor inhibits c-Jun-dependent stress-induced cell death by binding and modifying c-Jun activity in human breast cancer cells (English)

1 reference

22 September 2017

Xiaomei Qi

1

1 reference

22 September 2017

Stanley Borowicz

2

1 reference

22 September 2017

Rocky Pramanik

3

1 reference

22 September 2017

Richard M Schultz

4

1 reference

22 September 2017

Jiahuai Han

5

1 reference

22 September 2017

Guan Chen

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

24 November 2003

1 reference

Journal of Biological Chemistry

22 September 2017

published in

1 reference

22 September 2017

volume

279

1 reference

22 September 2017

issue

8

1 reference

22 September 2017

page(s)

6769-6777

1 reference

The regulation of AP-1 activity by mitogen-activated protein kinases

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Protective role for c-Jun in the cellular response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

The multifaceted mechanisms of estradiol and estrogen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

The p38 pathway provides negative feedback for Ras proliferative signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

The p65/RelA subunit of NF-kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Cooperation between STAT3 and c-jun suppresses Fas transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

c-Jun triggers apoptosis in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Characterization of the physical interaction between estrogen receptor alpha and JUN proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Nuclear receptor coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Hypoglycemia-induced c-Jun phosphorylation is mediated by c-Jun N-terminal kinase 1 and Lyn kinase in drug-resistant human breast carcinoma MCF-7/ADR cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311492200

21 January 2018

Identifiers

DOI

10.1074/JBC.M311492200

1 reference

22 September 2017

1 reference